| |
|
|
|
IBC Life Sciences, Hilton La Jolla Torrey Pines, San Diego, CA
March 15-17, 2004
With the enormous market size for off-patent biopharmaceuticals reaching several billion dollars by 2004, companies are strategically defining strategies to compete for the approximately $10 billion worth of biopharmaceuticals that will be coming off-patent in the next few years. IBC’s conference on Manufacturing Off-Patent Biologics: Navigating Regulatory and Technical Challenges will provide companies that are looking to manufacture comparable biologics with a complete understanding of regulatory, legal and technical issues encountered in developing a strategy to take advantage of this market.
|
|
|
|
|
|
|
|
Organized by:
|
|
IBC Liffe Sciences |
|
|
Invited Speakers:
|
|
Featured Presentations: Anthony R. Mire-Sluis, Ph.D., CDER, FDA
Chris Holloway, Ph.D., ERA Consulting, Germany
Inger Mollerup, Ph.D., Novo Nordisk, Denmark
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
-
|
|
|
|
|
|
|
|
Registration:
|
|
Online: www.LifeSciencesInfo.com/offpatent
Phone: (508) 616-5550
Fax: (508) 616-5522
E-mail: reg@ibcusa.com
|
|
|
E-mail:
|
|
reg@ibcusa.com
|
|
|
|
|
|
|
|
|